Studies genetic causes of heart rhythm problems in people with epilepsy
Looks for known inherited heart and brain genes in adults with epilepsy.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Genetic Markers of Cardiovascular Disease in Epilepsy
- Status
- Recruiting
- People taking part
- 600 people, planned
- Started
- May 2016
- Expected to end
- Dec 2031
- Type of study
- Observational, 2 groups
- Record updated
- 3 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 50 with epilepsy or seizures, fainting, drowning, cardiac arrest, sudden death or an abnormal heart tracing (ECG). Blood relatives aged 18 or older of such patients can also join.
- Age
- 18 to 50 years for patients; blood relatives must be 18 or older.
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of epilepsy or seizures, fainting (syncope), drowning, cardiac arrest, sudden death, or an abnormal ECG that suggests a heart rhythm problem.
Main reasons for not taking part
- Cannot give written consent
- Prisoners
- Seizures caused by ischemic events
- Seizures caused by traumatic brain injury
- History of cranial surgery or brain tumor
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adults ages 18 - 50 with a diagnosis of epilepsy or seizures, or syncope or drowning or cardiac arrest or sudden death or an abnormal ECG suggestive of an arrhythmia
- Blood-relatives (Aged 18+) of a patient with a history of epilepsy, seizure, cardiac arrest, sudden death, drowning, syncope or arrhythmia
Who cannot take part
- Seizures secondary to ischemic events
- Traumatic brain injury resulting in seizures
- History of cranial surgery
- History of brain tumor
- Those who are unable to provide written consent
- Prisoners (vulnerable population)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- Mayo ClinicRochester, United StatesContact: Erik K St. Louis, MD (sub-investigator)Taking people
About the trial
What the trial wants to find out
Epilepsy is a common condition which affects over 3 million people in the US. Patients with uncontrolled epilepsy have a lifetime risk of sudden unexpected death (SUDEP) of 35%, which is greatest in those under 40 years of age. The exact mechanisms and causes are not understood but can be due to underlying conditions which affect the heart and brain, which may lead to dangerous heart rhythms and death. Some of these conditions which affect heart and brain have an identifiable genetic cause. This study aims to identify known genetic causes of heart rhythm and sudden death related disorders in patients with epilepsy.
The 2 groups in the trial
- High SUDEP risk cohort
Patients with epilepsy who have a high SUDEP-7 risk score and/or a blood-relative with epilepsy, seizure, cardiac arrest, sudden death, drowning/near-drowning, syncope or arrhythmia.
- Low SUDEP risk cohort
Patients with epilepsy and a low SUDEP-7 score.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Genetic Markers of Cardiovascular Diseases and the Potential Role in Sudden Unexpected Death in Epilepsy.
- Plain-language title
- Studies genetic causes of heart rhythm problems in people with epilepsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT02824822, who can take part
- Record updated
- 3 November 2026